Prudential Financial’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.08M | Buy |
498,700
+665
| +0.1% | +$12.1K | 0.01% | 674 |
|
|
2025
Q1 | $9.88M | Sell |
498,035
-26,395
| -5% | -$524K | 0.01% | 593 |
|
|
2024
Q4 | $8.99M | Buy |
524,430
+5,897
| +1% | +$101K | 0.01% | 653 |
|
|
2024
Q3 | $10.4M | Buy |
518,533
+122,959
| +31% | +$2.46M | 0.01% | 666 |
|
|
2024
Q2 | $4.42M | Buy |
395,574
+359,238
| +989% | +$4.02M | 0.01% | 984 |
|
|
2024
Q1 | $240K | Buy |
36,336
+22,746
| +167% | +$150K | ﹤0.01% | 2417 |
|
|
2023
Q4 | $61.4K | Buy |
13,590
+550
| +4% | +$2.49K | ﹤0.01% | 2533 |
|
|
2023
Q3 | $46.7K | Hold |
13,040
| – | – | ﹤0.01% | 2508 |
|
|
2023
Q2 | $48.1K | Buy |
13,040
+980
| +8% | +$3.62K | ﹤0.01% | 2539 |
|
|
2023
Q1 | $39.9K | Buy |
12,060
+310
| +3% | +$1.03K | ﹤0.01% | 2520 |
|
|
2022
Q4 | $45.6K | Sell |
11,750
-3,700
| -24% | -$14.4K | ﹤0.01% | 2500 |
|
|
2022
Q3 | $38K | Sell |
15,450
-17,200
| -53% | -$42.3K | ﹤0.01% | 2584 |
|
|
2022
Q2 | $65K | Buy |
+32,650
| New | +$65K | ﹤0.01% | 2554 |
|
|
2021
Q2 | – | Sell |
-12,909
| Closed | -$23K | – | 2548 |
|
|
2021
Q1 | $23K | Buy |
12,909
+1,980
| +18% | +$3.53K | ﹤0.01% | 2477 |
|
|
2020
Q4 | $21K | Hold |
10,929
| – | – | ﹤0.01% | 2436 |
|
|
2020
Q3 | $26K | Buy |
+10,929
| New | +$26K | ﹤0.01% | 2409 |
|